Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab vs monthly Actonel in postmenopausal women transitioned from alendronate
2009-010587-42Phase 3Completed
- Sponsor
- Amgen
- Start
- May 2009
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in osteoporosis comparing Denosumab Q6M with Actonel QM (2 arms). Primary endpoint: Percent change from baseline in BMD at the total hip. Started May 2009; status: completed.
02
Drugs
denosumabrisedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2009-010587-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010587-42.